Close Menu

CHICAGO (GenomeWeb) – The Broad Institute this week released GATK4, the much-anticipated version 4 update to the Genome Analysis Toolkit, following a two-year redesign.

"It involved a fairly extensive reengineering of the underlying framework," said Geraldine Van der Auwera, associate director for outreach and communication for the Broad's Data Sciences Platform.

"We pretty much wrote everything from scratch," added Eric Banks, senior director of the Data Sciences Platform.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.